Related Experiment Video
Updated: Jul 27, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
Published on: June 28, 2021
Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as
Carlos Martínez-Torró1, Lorena Alba-Castellón2, Luis Miguel Carrasco-Díaz3
1Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
Abstract:
Two human proteins involved in the inflammatory cell death, namely Gasdermin D (GSDMD) and the Mixed Lineage Kinase Domain-Like (MLKL) protein have been engineered to accommodate an efficient ligand of the tumoral cell marker CXCR4, and a set of additional peptide agents that allow their spontaneous self-assembling. Upon production in bacterial cells and further purification, both proteins organized as stable nanoparticles of 46 and 54 nm respectively, that show, in this form, a moderate but dose-dependent cytotoxicity in cell culture. In vivo, and when administered in mouse models of colorectal cancer through repeated doses, the nanoscale forms of tumor-targeted GSDMD and, at a lesser extent, of MLKL promoted CD8+ and CD20+ lymphocyte infiltration in the tumor and an important reduction of tumor size, in absence of systemic toxicity. The potential of these novel pharmacological agents as anticancer drugs is discussed in the context of synergistic approaches to more effective cancer treatments.
Insights
Engineered Gasdermin D (GSDMD) and Mixed Lineage Kinase Domain-Like (MLKL) proteins form nanoparticles that target tumors. These novel agents reduce colorectal cancer size in mice by recruiting immune cells, without systemic toxicity.
Area of Science:
- Biochemistry
- Immunology
- Nanotechnology
Background:
- Gasdermin D (GSDMD) and Mixed Lineage Kinase Domain-Like (MLKL) are key proteins in inflammatory cell death.
- Targeting tumor cells and recruiting immune cells are crucial strategies in cancer therapy.
Purpose of the Study:
- To engineer GSDMD and MLKL proteins into tumor-targeted nanoparticles for cancer treatment.
- To evaluate the in vitro and in vivo efficacy and toxicity of these engineered proteins.
Main Methods:
- Proteins GSDMD and MLKL were engineered with a CXCR4 ligand and self-assembling peptides.
- Purified proteins formed stable nanoparticles (46-54 nm) and were tested for cytotoxicity in cell culture.
- Nanoparticles were administered to mouse models of colorectal cancer to assess in vivo effects.
Main Results:
- Engineered GSDMD and MLKL proteins self-assembled into nanoparticles with moderate, dose-dependent cytotoxicity in vitro.
- In vivo administration in colorectal cancer models promoted CD8+ and CD20+ lymphocyte infiltration into tumors.
- Significant tumor size reduction was observed without systemic toxicity.
Conclusions:
- Tumor-targeted GSDMD and MLKL nanoparticles show potential as novel anticancer agents.
- These nanoparticles can stimulate anti-tumor immune responses and reduce tumor growth.
- Further investigation into synergistic approaches with these agents is warranted for enhanced cancer treatment.
More Related Videos
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
07:04Immunostimulatory Agent Evaluation: Lymphoid Tissue Extraction and Injection Route-Dependent Dendritic Cell Activation
Published on: September 16, 2018
Related Concept Videos
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...